Copyright
©The Author(s) 2025.
World J Meta-Anal. Mar 18, 2025; 13(1): 101226
Published online Mar 18, 2025. doi: 10.13105/wjma.v13.i1.101226
Published online Mar 18, 2025. doi: 10.13105/wjma.v13.i1.101226
Table 1 Studies which were included in meta-analysis, n (%)
Ref. | Population | Number of IPAA | Normal pouch1 | Chronic pouchitis | Follow up period after IPAA | Definition of chronic pouchitis |
Abdelrazeq et al[3], 2008 | York Hospital, Huddersfield Royal Infirmary, Derby Hospitals–prospective | 198 | 134 (68) | 29 (15) | Mean 64 months (range: 12-180 months) | Presence of active symptoms continuously for more than 4 weeks despite full dose of standard therapy or required more than 2 weeks of therapy every month for three consecutive months to achieve symptomatic control |
Achkar et al[15], 2005 | Cleveland Clinic Foundation–prospective case control study | 120 | 40 (33) | 40 (33) | Mean 5.2 years | Presence of 4 or more episodes of pouchitis per year, or active symptoms lasting continuously for more than 4 weeks despite antibiotic therapy, or chronic antibiotic or anti-inflammatory therapy to control symptoms of pouchitis |
Ferrante et al[16], 2008 | University Hospital Gasthuisberg–retrospective | 173 | 92 (53) | 33 (19) | Median 6.5 years (range: 34-9.9 years) | Presence of active symptoms lasted for more than 4 weeks, despite standard therapy |
Fleshner et al[17], 2007 | Cedars-Sinar Medical Centre–prospective | 186 | 127 (68) | 23 (12) | Median 24 months (range: 3-117 months) | Required continuous antibiotic treatment for symptom relief or did not respond to antibiotic treatment |
Hashavia et al[18], 2012 | Tel-Aviv Sourasky Medical Centre– prospective | 201 | - | 63 (31) | Mean 107 months | Presence of at least 4 weeks of persistent symptoms and dependent on prolonged therapy of more than two different antibiotics, or those who did not respond to antibiotics |
Lian et al[19], 2009 | Cleveland Clinic Foundation–retrospective | 251 | 35 (14) | 29 (12) | - | Failed to respond to a 2-4 weeks course of a single antibiotic, or required therapy over 4 weeks with 2 antibiotics |
Okita et al[20], 2013 | Mie University–retrospective | 231 | 165 (71) | 31 (13) | Median 1882.5 days (range: 31-4465 days) | Required long-term, continuous antibiotic therapy to maintain remission, or relapsing episodes (> 3 per year), or failed to respond to antibiotics |
Scarpa et al[21], 2011 | University of Padova–prospective | 32 | - | 6 (19) | Median 23 months | No response to first line antibiotic therapy and required continuous antibiotic treatment for symptom relief or had a treatment resistant form |
Uchino et al[22], 2013 | Hyogo College of Medicine–retrospective | 772 | 695 (90) | 29 (4) | Median 5.67 years (range: 152-10.81 years) | Failed to respond to a 4-week course of a single antibiotic, requiring prolonged therapy for ≥ 4 weeks with ≥ 2 antibiotics or topical corticosteroid therapy |
Werner et al[23], 2013 | Tel Aviv Medical Centre–prospective | 36 | 10 (28) | 13 (36) | Follow up period was not mentioned | Required antibiotic or anti-inflammatory therapy for at least 4 weeks, or patients having more than 5 flares of pouchitis per year |
Wu et al[24], 2016 | Cleveland Clinic Pouch Centre–prospective | 1564 | 181 (12) | 217 (14) | Median 9 years (range: 4-14 years) | Symptoms lasted for 4 weeks or more and failed to respond to a 4-week course of single antibiotic therapy |
- Citation: Khoo E, Gilmore R, Griffin A, Holtmann G, Begun J. Risk factors associated with the development of chronic pouchitis following ileal-pouch anal anastomosis surgery for ulcerative colitis. World J Meta-Anal 2025; 13(1): 101226
- URL: https://www.wjgnet.com/2308-3840/full/v13/i1/101226.htm
- DOI: https://dx.doi.org/10.13105/wjma.v13.i1.101226